Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Beta-blockers are less effective at preventing stroke in older people with high blood pressure

A University of Leicester-led study may have uncovered the reason why Beta-blockers are less effective at preventing stroke in older people with high blood pressure, when compared to other drugs for high blood pressure.

27 Aug 2009

Stemedica unveils two of its latest scientific discoveries at the 2009 World Stem Cell Summit

Stemedica Cell Technologies , Inc., ("Stemedica"), a world leader in stem cell research and manufacturing (a licensed manufacturer of clinical grade biological products as licensed by the State of California Food and Drug Branch) continues to advance the stem cell industry with the presentation of two of its latest scientific discoveries at the 2009 World Stem Cell Summit.

27 Aug 2009

European Medicines Agency accepts reviewal of Merck's MAA for regulatory approval of vernakalant IV

Merck & Co., Inc., Whitehouse Station, NJ, USA, which operates in many countries as Merck Sharp & Dohme Limited, announced today that the European Medicines Agency (EMEA) accepted for review the Company’s Marketing Authorisation Application (MAA) for regulatory approval of vernakalant intravenous (IV).

27 Aug 2009

Kudzu vine root extracts may be developed as a dietary supplement for people with metabolic syndrome

Kudzu, the nuisance vine that has overgrown almost 10 million acres in the southeastern United States, may sprout into a dietary supplement.

27 Aug 2009

Oxygen Biotherapeutics to present at the Rodman & Renshaw Annual Global Investment Conference

Oxygen Biotherapeutics, Inc. today announced that the company will present at investor conferences in New York on Sept. 9 and Zurich on Sept. 10, 2009.

26 Aug 2009

MedAssets to deliver transformational revenue cycle solutions for Saint Barnabas Health Care System

MedAssets, Inc. today announced that it has signed a long-term agreement to deliver its transformational revenue cycle solutions to Saint Barnabas Health Care System (SBHCS), the largest integrated health care delivery system in New Jersey. MedAssets will provide revenue cycle process reengineering services, powered by the continued deployment of web-based software and execution of ongoing primary accounts receivable billing and follow-up services.

26 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Defentect's radiation detection system to be installed at Washington Hospital Center

Defentect announced today Washington Hospital Center is deploying Defentect's radiation detection system hospital-wide following a pilot project to test its effectiveness, with an additional nine GT2(TM) radiation sensors and two GT4(TM) Gamma Radiation sensors, capable of isotopic identification.

26 Aug 2009

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).

26 Aug 2009

Racial/ethnic disparities in clinically confirmed outcomes of heart and stroke surgeries

Minorities have poorer results and higher rates of unnecessary surgery from a common procedure used to remove plaque from inside the carotid artery, according to a UT Southwestern Medical Center doctor who is lead author of the study in the journal Stroke.

26 Aug 2009

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that study results demonstrated that arimoclomol exhibited both statistically significant neuroprotective and neuroregenerative effects in brain cells of animals induced with stroke, offering important insights into this drug candidate’s mechanism of action.

25 Aug 2009

Low-carbohydrate and high-protein diet increases the risk for atherosclerosis and impaired blood vessels

Even as low-carbohydrate/high-protein diets have proven successful at helping individuals rapidly lose weight, little is known about the diets' long-term effects on vascular health.

25 Aug 2009

Studies reveal that obese men are at increased risk for erectile dysfunction

Obese men are at increased risk for erectile dysfunction (ED), likely caused by atherosclerosis-related hypertension and cardiovascular disease, as well as hormonal changes associated with obesity, as described in a timely article published in Obesity and Weight Management, a journalzine published by Mary Ann Liebert, Inc.

25 Aug 2009

UCLA finds link between high cholesterol and osteoporosis

A new UCLA study sheds light on the link between high cholesterol and osteoporosis and identifies a new way that the body's immune cells play a role in bone loss

25 Aug 2009

People with high diastolic blood pressure more likely to have cognitive impairment

High blood pressure is linked to memory problems in people over 45, according to research published in the August 25, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.

24 Aug 2009

Study reveals that people over 60 and people with chronic diseases are most vulnerable to heat waves

People over the age of 60 are the most vulnerable to heat waves, with 82% to 92% more deaths than average occurring in this age group. Risks for heat-related illness or injury - such as heat stroke, heat exhaustion and heat cramps - are also heightened in people with obesity, heart disease, diabetes and respiratory conditions as these decrease the body's ability to adapt to temperature changes.

24 Aug 2009

University of Southern California's gerontology students participate in an interactive senior sensitivity training program

Gerontology students at University of Southern California had an opportunity to "become senior citizens" on Friday thanks to Trading Ages(TM), an interactive senior sensitivity training program sponsored by SCAN Health Plan.

24 Aug 2009

Thick blood to cause or prevent strokes and heart attacks proved by scientists

"Thick" blood can cause heart attack and stroke, but also prevent them. Scientists at Heidelberg University Hospital have explained the mechanism of this clinical paradox for the first time on an animal model. Mice with a greater tendency to form blood clots have larger plaques in their vessels, but they are more stable.

24 Aug 2009

Boston Micromachines Corporation's Multi-DM deformable mirrors being used for improving vision performance

Boston Micromachines Corporation, a leading provider of MEMS-based deformable mirror (DM) products for adaptive optics systems, announced today that its Multi-DM deformable mirror is being used at the University of Rochester Center for Vision Science's Yoon Lab in its research to improve vision performance.

24 Aug 2009

Israeli government and a private investment fund Brainstorm Cell Therapeutics to complete pre-clinical studies in ALS

BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease). The company expects to begin Phase I clinical studies in 2010.

24 Aug 2009

Stroke News and Research

Further Reading

Beta-blockers are less effective at preventing stroke in older people with high blood pressure

Stemedica unveils two of its latest scientific discoveries at the 2009 World Stem Cell Summit

European Medicines Agency accepts reviewal of Merck's MAA for regulatory approval of vernakalant IV

Kudzu vine root extracts may be developed as a dietary supplement for people with metabolic syndrome

Oxygen Biotherapeutics to present at the Rodman & Renshaw Annual Global Investment Conference

MedAssets to deliver transformational revenue cycle solutions for Saint Barnabas Health Care System

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Defentect's radiation detection system to be installed at Washington Hospital Center

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

Racial/ethnic disparities in clinically confirmed outcomes of heart and stroke surgeries

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

Low-carbohydrate and high-protein diet increases the risk for atherosclerosis and impaired blood vessels

Studies reveal that obese men are at increased risk for erectile dysfunction

UCLA finds link between high cholesterol and osteoporosis

People with high diastolic blood pressure more likely to have cognitive impairment

Study reveals that people over 60 and people with chronic diseases are most vulnerable to heat waves

University of Southern California's gerontology students participate in an interactive senior sensitivity training program

Thick blood to cause or prevent strokes and heart attacks proved by scientists

Boston Micromachines Corporation's Multi-DM deformable mirrors being used for improving vision performance

Israeli government and a private investment fund Brainstorm Cell Therapeutics to complete pre-clinical studies in ALS

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News